Trials / Sponsors / GRI Bio Operations, Inc.
GRI Bio Operations, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF Idiopathic Pulmonary Fibrosis, IPF | Phase 2 | 2024-04-24 |
| Terminated | Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease Chronic Liver Disease | Phase 2 | 2015-09-01 |